Who owns Etf Ser Solutions loncar cancer?

Tip: Access positions for across all investors

Analyze quarterly positions in Etf Ser Solutions loncar cancer with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Etf Ser Solutions loncar cancer stock

Who bought or sold Etf Ser Solutions loncar cancer this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Colony 43k $709k 37% Mar 2024
 View chart
Citadel Advisors 25k $411k 100% Mar 2024
 View chart
Morgan Stanley 19k $320k 448% Mar 2024
 View chart
Jane Street 12k $191k 100% Mar 2024
 View chart
Royal Bank of Canada 10k $173k -9% Mar 2024
 View chart
Prospera Financial Services 10k $135k 0% Dec 2023
 View chart
Blue Bell Private Wealth Management 723.00 $12k -49% Mar 2024
 View chart
Coastal Investment Advisors 539.00 $9.0k 100% Mar 2024
 View chart
Tower Research Capital 496.00 $8.2k 100% Mar 2024
 View chart
UBS Group 481.00 $8.0k -74% Mar 2024
 View chart
Advisor Group Holdings 276.00 $4.6k 84% Mar 2024
 View chart
SOA Wealth Advisors 150.00 $2.5k 0% Mar 2024
 View chart
Goss Wealth Management 100.00 $1.7k 0% Mar 2024
 View chart
Clear Point Advisors 27.00 $448.000200 0% Mar 2024
 View chart

Who sold out of Etf Ser Solutions loncar cancer?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2023 36k $399k
LPL Financial Sep 2023 12k $128k